Axsome Therapeutics News

Axsome Therapeutics | DEF 14A: Definitive information statements

Apr 27 04:40

Axsome Therapeutics | ARS: Annual Report to Security Holders

Apr 27 04:40

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jacobson Mark L.

Apr 2 06:48

Axsome Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 2 06:18

Axsome Therapeutics | 8-K: Current report

Apr 1 20:31

Axsome Therapeutics | 8-K: Current report

Mar 25 21:08

Axsome Therapeutics | 8-K: Current report

Mar 25 21:08

Axsome Therapeutics | 8-K: Current report

Mar 19 19:11

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director JEFFS ROGER

Mar 16 08:07

Axsome Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 16 07:12

Axsome Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 15 04:26

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director JEFFS ROGER

Mar 1 07:40

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Saad Mark E

Mar 1 07:40

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jacobson Mark L.

Mar 1 07:40

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pizzie Nick

Mar 1 07:29

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer TABUTEAU HERRIOT

Mar 1 07:24

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mahony Susan

Mar 1 07:24

Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Murdock Hunter R.

Mar 1 06:44

Axsome Therapeutics | 10-K: Annual report

Feb 23 21:14

Axsome Therapeutics | 8-K: Current report

Feb 21 05:37